节点文献

18F-FDG PET/CT代谢参数与非小细胞肺癌PD-L1表达相关性研究

The correlation between PD-L1 expression and metabolic parameters of 18F-FDG PET/CT in non-small cell lung cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 徐鑫李继会戴娜章斌桑士标邓胜明

【Author】 Xin Xu;Jihui Li;Na Dai;Bin Zhang;Shibiao Sang;Shengming Deng;Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University;State Key Laboratory of Radiation Medicine and Protection, Soochow University;

【通讯作者】 邓胜明;

【机构】 苏州大学附属第一医院核医学科放射医学与辐射防护国家重点实验室

【摘要】 目的:分析18F-FDG PET/CT代谢参数与非小细胞肺癌(non-small cell lung cancer,NSCLC)患者PD-L1表达的关系。方法:回顾性分析2019年3月至2021年7月于苏州大学附属第一医院行18F-FDG PET/CT显像的241例NSCLC患者临床资料,依据PD-L1表达状态分为阳性和阴性组、高表达和低表达组。Pearsonχ2检验比较组间分类变量的差异;t检验和Mann-Whitney U检验比较组间连续变量的差异。Logistic回归模型进行单因素和多因素分析。结果:在NSCLC中,PD-L1阳性组SUVmax、TLG均高于阴性组(P<0.05)。PD-L1高表达组SUVmax、MTV、TLG均高于低表达组(P<0.05)。鳞癌PD-L1阳性率、高表达率均高于腺癌(P<0.05)。在腺癌中,PD-L1阳性组、高表达组的SUVmax分别高于阴性组、低表达组(P<0.05),组间MTV、TLG差异无统计学意义(P>0.05)。在鳞癌中,代谢参数与PD-L1表达无明显相关性(P>0.05)。多因素分析表明,在NSCLC的腺癌中,SUVmax是PD-L1阳性的独立预测因素(P<0.05),也是PD-L1高表达的独立预测因素(P<0.05)。在ALK阴性腺癌中,SUVmax均是PD-L1阳性、高表达的独立预测因素(P<0.05)。结论:SUVmax能够预测腺癌患者PD-L1的表达状态,为免疫治疗提供依据。

【Abstract】 Objective: To investigate the relationship between metabolic parameters of 18F-fluorodeoxyglucose positron emission computed tomography(18F-FDG PET/CT) and the expression of programmed death-ligand 1(PD-L1) in patients with non-small cell lung cancer(NSCLC).Methods: A total of 241 NSCLC patients who received preoperative 18F-FDG PET/CT were retrospectively enrolled in the present study at The First Affiliated Hospital of Soochow University from March 2019 to July 2021. In terms of the expression of PD-L1, patients were assigned into positive and negative groups, and high expression and low expression groups. A Chi-square test was used to analyze the difference between the two categorical variables, while a Mann–Whitney U test or t-test was used for the continuous variables. Multivariate analyses between the expression of PD-L1 and characteristics were analyzed by Logistic regression analysis. Results: In NSCLC, the SUVmax and TLG of the PD-L1 positive group were higher than those of the negative group(P<0.05). SUVmax, MTV, and TLG in the PD-L1 high expression group were higher than those in the low expression group(P<0.05). PD-L1 positive and high expression rates were higher in squamous carcinoma(SCC) than in adenocarcinoma(ADC). In ADC, the SUVmax of PD-L1 positive and high expression groups were higher than those of the negative and low expression groups, respectively(P<0.05). In SCC, there was no significant correlation between metabolic parameters and PD-L1expression(P>0.05). Multivariate analysis revealed that SUVmax was an independent predictor of PD-L1 expression in NSCLC and ADC(P<0.05), as well as in ALK-negative ADC. C onclusions: The SUVmax of 18F-FDG PET/CT was a predictor of PD-L1 expression in ADC. It had important clinical value in immunotherapy.

【基金】 江苏省青年医学重点人才项目(编号:QNRC2016749);姑苏卫生青年拔尖人才项目(编号:GSWS2020013);苏州市民生科技计划项目(编号:SYS2019038);放射医学与辐射防护国家重点实验室项目(编号:GZK1202127)资助~~
  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2022年07期
  • 【分类号】R734.2
  • 【下载频次】129
节点文献中: 

本文链接的文献网络图示:

本文的引文网络